Hypermethylated Long Non-Coding RNA Genes KCNK15-AS1, MAGI2-AS3, and SSTR5-AS1 in Ovarian Cancer and Their Diagnostic...

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• Ovarian cancer diagnosis relies on methods with limitations.
• Aberrant DNA methylation is implicated in various cancers.
• Long non-coding RNAs (lncRNAs) are increasingly recognized for their roles in tumorigenesis.

Purpose of the Study:

• To identify novel diagnostic biomarkers for ovarian cancer.
• To investigate the role of aberrant methylation in lncRNA genes as potential diagnostic markers.
• To evaluate the diagnostic accuracy of a panel of methylated lncRNA genes.

Main Methods:

• Analysis of DNA methylation in lncRNA genes using quantitative methyl-specific PCR.
• Assessment of lncRNA gene expression using quantitative reverse transcription PCR.
• Statistical analysis including Mann-Whitney test and ROC analysis for diagnostic potential evaluation.

Main Results:

• Significant increase in methylation levels of three lncRNA genes (KCNK15-AS1, MAGI2-AS3, SSTR5-AS1) in ovarian cancer tissues (p < 0.01).
• Significant decrease in the expression of these three lncRNA genes in tumor samples (p < 0.01).
• Methylation of these genes showed a significant inverse correlation with their expression (r < -0.5), indicating methylation-driven suppression.
• A diagnostic panel based on methylation of these three genes achieved 98% sensitivity and 100% specificity for ovarian cancer detection (AUC = 0.989).

Conclusions:

• Aberrant methylation of KCNK15-AS1, MAGI2-AS3, and SSTR5-AS1 serves as a promising diagnostic marker for ovarian cancer.
• The developed marker panel demonstrates high diagnostic accuracy and potential for early detection.
• Further validation on larger cohorts is necessary to confirm clinical utility.